56.10
+3.00
+(5.65%)
At close: January 17 at 5:35:19 PM GMT+1
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
200,143.00
189,677.00
-144,228.00
384,886.00
459,980.00
Investing Cash Flow
-40,599.00
-67,341.00
36,826.00
-109,919.00
-263,085.00
Financing Cash Flow
-154,325.00
-154,561.00
-29,381.00
-334,644.00
114,252.00
End Cash Position
186,508.00
271,956.00
311,554.00
445,746.00
497,330.00
Capital Expenditure
-58,240.00
-68,211.00
-86,859.00
-110,342.00
-114,940.00
Issuance of Capital Stock
--
3,066.00
3,328.00
4,464.00
79,000.00
Issuance of Debt
41,349.00
197,107.00
36,677.00
108,815.00
110,674.00
Repayment of Debt
-112,913.00
-91,737.00
-17,035.00
-138,165.00
-22,004.00
Repurchase of Capital Stock
204,844.00
-3,962.00
-4,549.00
-5,952.00
-7,284.00
Free Cash Flow
141,903.00
121,466.00
-231,087.00
274,544.00
345,040.00
12/31/2020 - 11/12/1998
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
PHI1.DE Koninklijke Philips N.V.
25.09
+0.84%
AAQ1.DE aap Implantate AG
1.8900
+8.62%
GME.DE Geratherm Medical AG
3.6800
+2.22%
E8X.DE elexxion AG
0.2620
+9.17%
GTN.BE Getinge AB
16.53
+1.29%
SBS.DE Stratec SE
32.10
+7.00%
ABL.DE Abbott Laboratories
110.38
+0.91%
BSX.DE Boston Scientific Corporation
96.00
+1.05%
2M6.DE Medtronic plc
85.32
+2.19%
GETI-B.ST Getinge AB (publ)
192.70
+1.00%